|
IREB2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.01840000000542E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.978000E-02 |
| Normal-vs-Stage2 |
1.055160E-01 |
| Normal-vs-Stage3 |
8.23389999515811E-08 |
| Normal-vs-Stage4 |
2.21610000017414E-07 |
| Stage1-vs-Stage2 |
6.152000E-01 |
| Stage1-vs-Stage3 |
3.60830000000201E-05 |
| Stage1-vs-Stage4 |
1.206470E-04 |
| Stage2-vs-Stage3 |
4.074400E-02 |
| Stage2-vs-Stage4 |
3.350200E-02 |
| Stage3-vs-Stage4 |
7.584400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.22750000000205E-05 |
| Normal-vs-AfricanAmerican |
9.69370000000191E-05 |
| Normal-vs-Asian |
3.685800E-01 |
| Caucasian-vs-AfricanAmerican |
2.294200E-01 |
| Caucasian-vs-Asian |
6.779200E-01 |
| AfricanAmerican-vs-Asian |
3.243400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.87319999994862E-06 |
| Normal-vs-Female |
9.001100E-03 |
| Male-vs-Female |
6.954300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.523940E-03 |
| Normal-vs-Age(41-60Yrs) |
8.462100E-03 |
| Normal-vs-Age(61-80Yrs) |
4.5186999999558E-06 |
| Normal-vs-Age(81-100Yrs) |
3.777200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.203200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.484200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.425800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.540400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.304990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.126400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.305800E-01 |
| Normal-vs-Grade 2 |
1.111230E-01 |
| Normal-vs-Grade 3 |
6.20260000028239E-07 |
| Normal-vs-Grade 4 |
2.47819542664729E-11 |
| Grade 1-vs-Grade 2 |
2.497600E-01 |
| Grade 1-vs-Grade 3 |
5.437600E-03 |
| Grade 1-vs-Grade 4 |
1.6730599999959E-05 |
| Grade 2-vs-Grade 3 |
2.630000E-04 |
| Grade 2-vs-Grade 4 |
3.5310999679794E-09 |
| Grade 3-vs-Grade 4 |
3.118500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.262800E-01 |
| Normal-vs-ccB subtype |
3.19650000024652E-07 |
| ccA subtype-vs-ccB subtype |
4.21009999973521E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.517550E-03 |
| Normal-vs-N1 |
2.842000E-02 |
| N0-vs-N1 |
2.022200E-01 |
|
|
